Catalys Pacific, LLC — Q1 2025 13F-HR

← Catalys Pacific, LLC

Q1 2025 · 13F-HR

Catalys Pacific, LLCholdings as filed

Filed 2025-05-14 · accession 0001104659-25-048317

$148.7M

Reported value

Positions

2025-03-31

Period end

View analyzed profile →PRO

The Brief · Catalys Pacific, LLC · Q1 2025

AI · grounded in 13F

Catalys Pacific, LLC reported no changes to its 13F holdings for 2025-03-31 relative to 2024-12-31.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
603170101	MLYS	Mineralys Therapeutics, Inc.	$141.4M	95.1%	8,644,579	Common	SOLE
71722W107	PHAT	Phathom Pharmaceuticals, Inc.	$7.3M	4.92%	1,167,114	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.